| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amgen Inc (AMGN) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AMGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.2K | $174.14M | - | |
| VP | 83.4K | $28.74M | - | |
| VP | 51.2K | $17.66M | - | |
| CFO | 50.7K | $17.48M | - | |
| VP | 42.8K | $14.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2018 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $195.71 | $298,457.75 | -2.6% | |
| Jun 12, 2018 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $184.27 | $281,011.75 | -2.6% | |
| May 14, 2018 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $174.10 | $265,502.50 | -2.5% | |
| Apr 12, 2018 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $172.68 | $263,337.00 | -2.6% | |
| Mar 16, 2018 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $189.75 | $289,368.75 | -2.3% | |
| Feb 14, 2018 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $174.18 | $265,624.50 | -2.8% | |
| Jan 16, 2018 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $185.62 | $283,070.50 | -2.7% | |
| Dec 12, 2017 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $176.83 | $269,665.75 | -2.6% | |
| Nov 13, 2017 | Harper Sean E | EVP, Research &Development | Sell | 1,525 | $171.58 | $261,659.50 | -2.6% | |
| Nov 8, 2017 | De Carbonnel Francois | Director | Sell | 4,000 | $173.61 | $694,422.00 | -20.5% |